AL
SPHS

Airain Ltd’s Sophiris Bio, Inc. SPHS Stock Holding History

Airain Ltd’s Portfolio SPHS Stock Details SPHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-35,697
Closed -$100K – 1100
2016
Q4 		$100K Sell
35,697
-28,033
-44% -$79.4K 0.01% 631
2016
Q3 		$198K Buy
63,730
+31,713
+99% +$119K 0.01% 530
2016
Q2 		$69K Buy
+32,017
New +$44.2K ﹤0.01% 614

Other funds holding SPHS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SMV
Sofinnova Management VIII Menlo Park, California $183M AUM 4.18% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Airain Ltd's SPHS Position: Q1 2017 in Review

Airain Ltd sold out of Sophiris Bio, Inc. (SPHS) in Q1 2017, closing a stake of 35,697 shares — an estimated $100K sold.

Airain Ltd first reported a position in SPHS in Q2 2016 and held it in 3 quarters. The position peaked at $198K in Q3 2016. 31 funds tracked by Wall St. Rank hold SPHS as of Q1 2017.

  • Airain Ltd reported no remaining Sophiris Bio, Inc. position as of Q1 2017 after selling out during the quarter.
  • Airain Ltd sold 35,697 Sophiris Bio, Inc. shares in Q1 2017, an estimated $100K.
  • Airain Ltd first reported a position in Sophiris Bio, Inc. in Q2 2016 and held it in 3 quarters.
  • Airain Ltd's Sophiris Bio, Inc. position peaked at $198K in Q3 2016.
  • 31 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2017.

Based on Airain Ltd's 13F filing for Q1 2017, filed 9 May 2017.